000 01251 a2200325 4500
005 20250515051339.0
264 0 _c20070417
008 200704s 0 0 eng d
022 _a1040-8428
024 7 _a10.1016/j.critrevonc.2006.10.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Amy M
245 0 0 _aIntermittent chemotherapy for metastatic hormone refractory prostate cancer.
_h[electronic resource]
260 _bCritical reviews in oncology/hematology
_cMar 2007
300 _a243-54 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Metastasis
_xdrug therapy
650 0 4 _aNeoplasms, Hormone-Dependent
_xdrug therapy
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aRyan, Charles J
700 1 _aSmall, Eric J
773 0 _tCritical reviews in oncology/hematology
_gvol. 61
_gno. 3
_gp. 243-54
856 4 0 _uhttps://doi.org/10.1016/j.critrevonc.2006.10.002
_zAvailable from publisher's website
999 _c16730293
_d16730293